This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
CAMKK2 / Calcium/calmodulin-dependent protein kinase kinase 2 · IHC design guide
Design Immunohistochemistry for CAMKK2
Plan CAMKK2 paraffin IHC with cortical neurons as a high-staining reference (HPA tissue IHC). This guide covers fixation consistency, cytoplasmic scoring (HPA tissue IHC), and the catalog antibody’s 2–5 μg/ml IHC range (datasheet A03048).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
CAMKK2 Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Predominantly cytoplasmic tissue staining (HPA tissue IHC) | |
| Staining pattern | General cytoplasmic staining; high in cortical neurons (HPA tissue IHC) | |
| Antigen retrieval | EDTA pH 8.0 HIER, heat-mediated (datasheet A03048) | |
| Positive control | Cerebral cortex+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Keep fixation conditions consistent across sections (standard IHC practice; not target-specific) | |
| Caveat | Low consistency between antibody staining and RNA (HPA tissue IHC) | |
| Regulation | Higher expression in brain (UniProt) | |
| Isoform / epitope | 7 isoforms; 4–6 lack part of the calmodulin-binding domain (UniProt) |
Section 1
Recommended CAMKK2 IHC & IF Protocols
The catalog antibody uses heat-mediated EDTA pH 8.0 retrieval (datasheet A03048). The two published CAMKK2 IHC protocols use citrate pH 6.0 retrieval (PMC10472110; PMC6547743).
| Sample | Paraffin-embedded human colorectal adenocarcinoma tissue; fixative not specified (datasheet A03048) |
| Fixation | Image fixative and duration unreported (datasheet A03048); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: EDTA pH 8.0 (datasheet A03048); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A03048) |
| Primary antibody | Rabbit anti-CAMKK2, 2-5 μg/ml (datasheet A03048) |
| Primary incubation | Overnight at 4 °C (datasheet A03048) |
| Detection | HRP-conjugated secondary, DAB chromogen (datasheet A03048) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | CAMKK2-positive staining in neuronal cells of cerebral cortex (HPA tissue IHC: High). HPA tissue profile: General cytoplasmic expression. No signal in the no-primary control. |
💡Decision noteStart with EDTA pH 8.0 for the catalog antibody (datasheet A03048); consider citrate pH 6.0 during optimization (PMC10472110; PMC6547743).
Section 2
What Is the Expected CAMKK2 Staining Pattern?
In paraffin-section IHC, expect mainly cytoplasmic CAMKK2 staining in cerebral cortical neurons and selected squamous epithelial and glandular cells (HPA: general cytoplasmic expression; High in these cell types). CAMKK2 has no transmembrane segment (UniProt Q96RR4 topology). Interpret intensity cautiously: HPA rates tissue IHC Approved but reports low consistency between staining and RNA expression (HPA: reliability summary).
| Cytoplasmic staining in cerebral cortical neurons. | This fits a strong positive tissue pattern (HPA: High in cerebral cortex neuronal cells; general cytoplasmic expression). Judge the relevant cells, rather than the section as a whole. |
| Predominantly sharp membrane or extracellular staining. | This conflicts with the expected intracellular pattern (HPA: general cytoplasmic expression; UniProt Q96RR4: no transmembrane segment). Review morphology, controls and detection background before scoring it as CAMKK2. |
| Strong staining in adipocytes or skeletal myocytes. | These cell types are listed as Not detected (HPA: adipose tissue adipocytes; skeletal muscle myocytes). Investigate cross-reactivity or endogenous detection activity; an isolated signal there is weak evidence of CAMKK2. |
| Uniform color across cells and cell-free areas. | A pattern that ignores cell boundaries suggests diffuse assay background (general IHC practice). Compare the no-primary control and inspect blocking, washing and chromogen development before interpreting cell-specific staining. |
| No staining in a cerebral cortex positive control. | The result conflicts with the reported High neuronal staining (HPA: cerebral cortex). Check tissue preservation, retrieval, antibody dilution and detection with suitable controls (general IHC practice); do not infer CAMKK2 absence from this slide alone. |
💡Expected CAMKK2 appearanceCall positive a predominantly cytoplasmic signal in cortical neurons or the specified squamous epithelial or glandular cells, potentially strong in HPA High groups; membrane-only, extracellular or cell-independent color is suspect (HPA: tissue IHC profile and levels; UniProt Q96RR4 topology).
| Positive and negative tissue choice | Cerebral cortex neurons, prostate glandular cells and esophageal squamous cells are High; adipocytes and skeletal myocytes are Not detected (HPA: tissue IHC). Use the named cell populations when comparing sections. |
| Localization and cell state | HPA describes general cytoplasmic tissue staining (HPA: tissue IHC). UniProt reports predominantly nuclear CAMKK2 in unstimulated cells and movement into cytoplasm and neurites after forskolin induction (UniProt Q96RR4: subcellular location). Context matters when assessing nuclear signal. |
| Antibody evidence and isoforms | Two listed antibodies have Approved IHC status, while HPA reports low staining–RNA consistency (HPA: antibody validation and reliability summary). UniProt lists seven isoforms (UniProt Q96RR4: isoforms); the payload gives no epitope map or isoform coverage for the catalog antibody. |
| IF/ICC Q&A | Q: What localization is reported for IF/ICC? A: Cytosol is the supported main location; HPA017389 has Supported ICC status (HPA: subcellular ICC-IF and antibody validation). This is context for the separate IF/ICC guide, not an IHC protocol option. |
| Situation | Likely cause | Next action |
|---|---|---|
| Weak staining in cerebral cortex neurons | The expected population is High (HPA: cerebral cortex neuronal cells); the assay may have insufficient detectable signal. | Check the positive control, then review retrieval, antibody dilution and detection conditions (general IHC practice). No CAMKK2-specific retrieval setting is supplied. |
| No stain in both test and positive-control sections | A shared processing or detection failure is possible (general IHC practice); cortex neurons should stain strongly (HPA: High). | Verify section integrity and each staining step with appropriate controls before calling the test tissue negative (general IHC practice). |
| Strong color in HPA Not detected cells | Adipocytes and skeletal myocytes are Not detected in the HPA tissue profile (HPA: tissue IHC). Cross-reactivity or endogenous detection activity may explain color. | Compare a no-primary control and an appropriate positive tissue; review blocking and detection reagents (general IHC practice). |
| Diffuse stain obscures cell boundaries | Excess detection background can prevent cellular scoring (general IHC practice). | Compare the no-primary control; review washing, antibody concentration and chromogen development (general IHC practice). Score only distinguishable cellular staining. |
| Prominent nuclear stain with little cytoplasmic stain | UniProt reports nuclear predominance in unstimulated cells, whereas HPA summarizes tissue IHC as generally cytoplasmic (UniProt Q96RR4: location; HPA: tissue profile). | Record the compartment and specimen context; compare HPA positive cells and controls before accepting a nuclear-only tissue pattern. |
| Unexpected difference between two positive tissues | HPA reports High staining in several cell types but low consistency with RNA expression (HPA: tissue levels and reliability summary). Tissue-wide intensity may also hide cell-specific patterns. | Score the named cells separately, verify comparable staining runs, and interpret intensity with the HPA reliability caveat (general IHC practice; HPA: reliability summary). |
Experiment evidence
IHC & IF images showing CAMKK2 staining
A03048 · IHCIHC analysis of CAMKK2 using anti-CAMKK2 antibody (A03048). CAMKK2 was detected in a paraffin-embedded section of human colorectal adenocarc
A03048 · IHCIHC analysis of CAMKK2 using anti-CAMKK2 antibody (A03048). CAMKK2 was detected in a paraffin-embedded section of human esophageal squamous
A03048 · IFIF analysis of CAMKK2 using anti-CAMKK2 antibody (A03048). CAMKK2 was detected in an immunocytochemical section of PC-3 cells. Enzyme antige
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000110931-CAMKK2/tissue/cerebral+cortex#imid_4870760
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000110931-CAMKK2/tissue/colon#imid_4870678
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000110931-CAMKK2/tissue/liver#imid_4870687
HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000110931-CAMKK2/tissue/kidney#imid_4870680
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA017389; green = CAMKK2, blue = nucleus, red = microtubules.
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA017389; green = CAMKK2, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for CAMKK2 IHC & IF
🧪Run cerebral cortex first and expect neuronal cells to stain (HPA: cerebral-cortex neuronal cells High); pair it with adipose tissue, where adipocytes are not detected (HPA: adipose-tissue adipocytes Not detected). HPA identifies no internal negative cell type on the cortex slide, so use unstained neighboring cells as local background without assuming they lack CAMKK2 (HPA: cerebral-cortex neuronal cells High; internal negatives unspecified).
Positive control tissue: Cerebral cortex (Neuronal cells, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show CAMKK2 in A-431, U-251MG, U2OS, ASC52telo, hTERT-RPE1 (serum starved), with annotated localisation: Cytosol (supported) (HPA subcellular).
Technical controls: Include a no-primary, secondary-only control and a concentration-matched rabbit IgG isotype control (caption: rabbit primary; standard IHC practice); use a validated CAMKK2-knockout specimen as a biological negative if available (standard IHC practice). In cortex, quench endogenous peroxidase and distinguish neuronal lipofuscin pigment from DAB staining (standard IHC practice).
⚠️Feasibility: A target-specific fixation window or fixation effect is unreported, and the selected A03048 paraffin-section caption does not state a fixative (caption: fixative unreported). The caption uses heat-mediated EDTA retrieval at pH 8.0, but target-specific retrieval dependence is unreported (caption: EDTA pH 8.0). The supplied evidence does not establish whether frozen sections or IF are easier for CAMKK2; cortical neuronal lipofuscin may complicate DAB interpretation (standard IHC practice).
HPA tissue IHC evidence for CAMKK2
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Approved — Low consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Cerebral cortex | Neuronal cells | High | Protein (IHC) | HPA → |
| Esophagus | Squamous epithelial cells | High | Protein (IHC) | HPA → |
| Oral mucosa | Squamous epithelial cells | High | Protein (IHC) | HPA → |
| Parathyroid gland | Glandular cells | High | Protein (IHC) | HPA → |
| Prostate | Glandular cells | High | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Fallopian tube | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Seminal vesicle | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Skeletal muscle | Myocytes | Not detected | Protein (IHC) | HPA → |
| Soft tissue | Fibroblasts | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced CAMKK2 IHC Tips
Troubleshoot CAMKK2 chromogenic IHC in paraffin sections using the catalog antibody’s tissue image and the reported tissue and subcellular patterns (datasheet A03048; HPA).
What retrieval should I try first when CAMKK2 staining is weak?
Use heat-mediated retrieval in EDTA at pH 8.0 for CAMKK2 paraffin-section IHC (datasheet A03048). The documented tissue image also used 2 μg/ml primary antibody overnight at 4°C, so keep those conditions consistent while assessing retrieval (datasheet A03048). Compare a retrieved section with an otherwise matched section that received no retrieval, and inspect whether staining increases in cells rather than only along section edges (standard IHC practice). If staining remains weak, test another retrieval buffer or pH on adjacent sections as a fallback, holding antibody concentration and detection constant (standard IHC practice). Record heat exposure and tissue preservation for each condition because excessive retrieval can impair morphology and complicate scoring (standard IHC practice).
Could fixation explain inconsistent CAMKK2 staining between paraffin blocks?
Target-specific CAMKK2 sensitivity to fixation is unknown: the selected paraffin-section image does not state its fixative (datasheet A03048). Record each block’s documented fixative and fixation duration, then compare sections processed with the same retrieval, antibody concentration, and detection conditions (standard IHC practice). Assess nuclear detail and tissue integrity alongside staining, since poor preservation can make a staining difference difficult to interpret (standard IHC practice). If blocks differ in fixation history, first compare similarly processed specimens before attributing signal changes to CAMKK2 abundance (standard IHC practice). Do not infer a CAMKK2 fixation effect from its reported tissue distribution or intracellular localisation (HPA; UniProt Q96RR4).
Should CAMKK2 staining be nuclear or cytoplasmic in tissue sections?
Assess cytoplasmic staining first, because the tissue IHC profile reports general cytoplasmic expression (HPA tissue IHC). Nuclear staining can warrant investigation: CAMKK2 is reported as predominantly nuclear in unstimulated cells and able to relocate into cytoplasm and neurites after forskolin induction (UniProt Q96RR4). In each section, score nuclear and cytoplasmic compartments separately, using a counterstain to identify nuclei and checking whether staining follows intact cell boundaries (standard IHC practice). Do not treat localisation alone as proof of stimulation, because the tissue IHC profile and the reported cell-state observation describe different contexts (HPA tissue IHC; UniProt Q96RR4). Compare the compartment pattern across replicate sections and relevant cell populations before assigning a biological explanation (standard IHC practice).
Can this stain distinguish active CAMKK2 isoforms or phosphorylation states?
Do not assign an isoform or phosphorylation state from this chromogenic stain unless the antibody epitope and relevant cross-reactivity have been established (standard IHC interpretation). CAMKK2 has 7 reported isoforms, and isoforms 4–6 lack part of the calmodulin-binding domain and are described as inactive (UniProt Q96RR4). Reported modified residues include phosphoserines at positions 100, 114, 129, and 133, but their presence in the record does not establish phospho-specific recognition by this antibody (UniProt Q96RR4). Check the antibody’s documented immunogen or epitope against the isoforms under study, and use a separately validated phospho-specific assay if phosphorylation is the research endpoint (standard IHC practice). Describe the present result as CAMKK2 immunoreactivity unless that specificity work supports a narrower claim (standard IHC interpretation).
How should I assess CAMKK2 by multiplex IF alongside this IHC guide?
Plan IF as a separate assay, since the documented CAMKK2 tissue workflow here uses chromogenic detection in a paraffin section (datasheet A03048). Multiplex CAMKK2 with a marker for the cell population being evaluated, such as a neuronal-cell marker when examining cerebral cortex, where neuronal staining is reported high (HPA tissue IHC). Choose a fluorophore channel with low measured tissue autofluorescence, and acquire single-label controls to check bleed-through before interpreting overlap (standard IF practice). CAMKK2 has no transmembrane segment and has reported intracellular locations, so include permeabilisation when staining an intracellular epitope, while checking its effect on morphology (UniProt Q96RR4; standard IF practice). Establish IF fixation and antibody conditions independently; the selected tissue caption does not report fixation (datasheet A03048).
How do I separate CAMKK2 signal from DAB background?
The documented tissue image used 10% goat-serum blocking, a peroxidase-conjugated secondary antibody, and DAB development (datasheet A03048). Include a no-primary control and inspect its staining before interpreting diffuse pigment as CAMKK2 immunoreactivity (standard IHC practice). Block endogenous peroxidase as a general chromogenic IHC step, then compare the control and test sections under the same development conditions (standard IHC practice). If background persists, check secondary-antibody binding, washing, and DAB development while changing one variable at a time (standard IHC practice). Judge a revised condition by preservation of cellular staining and morphology, including the expected cytoplasmic pattern, rather than by loss of all colour (HPA tissue IHC; standard IHC practice).
How should I quantify CAMKK2 staining across tissue sections? ⚠ ANSWER MARKED FOR VERIFICATION
Define the cell population and compartment before scoring, because CAMKK2 tissue IHC is reported as generally cytoplasmic (HPA tissue IHC). For intact cells, record the percentage stained and intensity scores of 0–3; an H-score then ranges from 0–300 (standard IHC scoring practice). Alternatively, report positive cells per mm² when cellular density is the endpoint, excluding folds, necrotic regions, and section edges by a consistent rule (standard IHC practice). Normalise cell counts to the evaluated viable tissue area, and compare H-scores within the same defined cell population and staining batch (standard IHC practice). Keep exposure-independent image settings and scoring thresholds consistent, and report how background was assessed with control sections (standard IHC practice).
When is apparent CAMKK2 positivity likely to be artefactual?
Treat a coherent cellular pattern as more persuasive than pigment concentrated at cut edges, folds, or necrotic areas, which warrant review as staining artefacts (standard IHC practice). CAMKK2 tissue IHC is generally cytoplasmic, while reported neuronal cells in cerebral cortex and glandular cells in prostate stain high; identify the stained cell type before drawing a conclusion (HPA tissue IHC). Nuclear signal is not automatically false because unstimulated-cell nuclear localisation is reported, but an unexpected compartment pattern needs independent confirmation (UniProt Q96RR4; standard IHC interpretation). Check no-primary controls for endogenous-enzyme or detection background when using peroxidase and DAB (standard IHC practice; datasheet A03048). Interpret weak or discordant staining cautiously because the tissue IHC record reports low consistency between antibody staining and RNA expression (HPA tissue IHC).
Boster reagents
Best CAMKK2 / Calcium/calmodulin-dependent protein kinase kinase 2 IHC Antibodies
A03048 has IHC images from human tumor and mouse brain paraffin sections, plus IF images from cultured cells and a human intestinal cancer paraffin section (catalog image captions).
Real IHC data
Anti-CAMKK2 Antibody ®
Cat # A03048
A03048 has IHC images from human colorectal adenocarcinoma, esophageal squamous carcinoma and liver cancer paraffin sections, and mouse brain paraffin sections (catalog IHC captions). A03048 also has IF images from PC-3 and Hela cells and a human intestinal cancer paraffin section; the catalog lists human, mouse and rat reactivity (catalog IF captions; catalog reactivity).
Which to pick: Choose A03048 for tissue IHC on paraffin sections: its IHC captions document EDTA retrieval at pH 8.0 and primary antibody at 2 μg/ml; the fixative is unreported (catalog IHC captions). For IF/ICC, A03048 has images from PC-3 and Hela cells and a human intestinal cancer paraffin section, with a listed IF dilution of 5 μg/ml (catalog IF captions; catalog dilution). For cross-species work, A03048 lists human, mouse and rat reactivity, while its IHC images show human and mouse samples; clonality is unreported (catalog reactivity; catalog IHC captions; catalog clone field).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry Q96RR4 (KKCC2_HUMAN, Calcium/calmodulin-dependent protein kinase kinase 2).
- Human Protein Atlas. CAMKK2 tissue IHC expression (reliability: Approved).
- Human Protein Atlas. CAMKK2 subcellular location (ICC-IF): Localized to the cytosol..
- Human Protein Atlas. CAMKK2 antibody validation summary (2 antibodies).
- The prognostic value and immunological role of calcium/calmodulin dependent protein kinase kinase 2 (CAMKK2) in pan-cancer study. Medicine 2024 — PMC11479412.
- Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis. Cancer research 2023 — PMC10472110.
- Loss of CAMKK2 and iron-transport proteins-transferrin and its receptor-in the Alzheimer's disease hippocampus: link to tau pathology. Frontiers in cell and developmental biology 2026 — PMC12872923.
- CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer. Nature communications 2019 — PMC6547743.
- PubMed PMID:11395482 — UniProt-cited evidence.
- PubMed PMID:9822657 — UniProt-cited evidence.
- PubMed PMID:12935886 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for CAMKK2 (Calcium/calmodulin-dependent protein kinase kinase 2). Expected localisation Predominantly cytoplasmic tissue staining (HPA tissue IHC). Antigen retrieval: EDTA pH 8.0 HIER, heat-mediated (datasheet A03048). Validated IHC antibody: A03048 at 2-5 μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Cerebral cortex (Neuronal cells); negative Adipose tissue. IHC-P workflow on paraffin sections; fixative unspecified. Protocol steps: 1. Sample: Paraffin-embedded human colorectal adenocarcinoma tissue; fixative not specified (datasheet A03048); 2. Fixation: Image fixative and duration unreported (datasheet A03048); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: EDTA pH 8.0 (datasheet A03048); 20 min, 95–100 °C (standard); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet A03048); 8. Primary antibody: Rabbit anti-CAMKK2, 2-5 μg/ml (datasheet A03048); 9. Primary incubation: Overnight at 4 °C (datasheet A03048). Watch for: Fixation: Keep fixation conditions consistent across sections (standard IHC practice; not target-specific); Caveat: Low consistency between antibody staining and RNA (HPA tissue IHC); Isoform / epitope: 7 isoforms; 4–6 lack part of the calmodulin-binding domain (UniProt); Regulation: Higher expression in brain (UniProt). Evidence: UniProt Q96RR4, HPA tissue IHC · Approved, HPA ICC-IF · cytosol., Datasheet A03048, PMC10472110, PMC6547743. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/CAMKK2/immunohistochemistry-ihc-guide.